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The rnt-1 gene is the only Caenorhabditis elegans homologue of the mammalian RUNX genes. Several lines of molecular biological
evidence have demonstrated that the RUNX proteins interact and cooperate with Smads, which are transforming growth factor-h (TGF-h)
signal mediators. However, the involvement of RUNX in TGF-h signaling has not yet been supported by any genetic evidence. The Sma/
Mab TGF-h signaling pathway in C. elegans is known to regulate body length and male tail development. The rnt-1(ok351) mutants show
the characteristic phenotypes observed in mutants of the Sma/Mab pathway, namely, they have a small body size and ray defects. Moreover,
RNT-1 can physically interact with SMA-4 which is one of the Smads in C. elegans, and double mutant animals containing both the rnt-
1(ok351) mutation and a mutation in a known Sma/Mab pathway gene displayed synergism in the aberrant phenotypes. In addition, lon-
1(e185) mutants was epistatic to rnt-1(ok351) mutants in terms of long phenotype, suggesting that lon-1 is indeed downstream target of rnt-
1. Our data reveal that RNT-1 functionally cooperates with the SMA-4 proteins to regulate body size and male tail development in C.
elegans.
D 2004 Elsevier Inc. All rights reserved.
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1 These authors contributed equally to this work.development and growth. The dpp/BMP subfamily regulates
many developmental events, including dorsal–ventral pat-
terning, mesoderm induction, and osteogenesis (Irish and
Gelbart, 1987; Panganiban et al., 1990; Wozney et al., 1988).
For example, in Drosophila, dpp, Gbb-60A, and screw,
which encode TGFh-like ligands, are required during the
embryonic and/or the pupal stages to regulate development
(Arora et al., 1994; Chen et al., 1998; Khalsa et al., 1998;
Padgett et al., 1987). Moreover, in Caenorhabditis elegans,
the dbl-1, unc-129, and daf-7 genes, which encode divergent
TGFh-like ligands, are involved in body length and male tail
development (Krishna et al., 1999), axon guidance (Colavita
et al., 1998), and dauer formation (Ren et al., 1996),
respectively.
Two classes of receptor kinases for the TGF-h super-
family have been identified, namely, the type I and type II274 (2004) 402–412
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threonine receptor kinase complexes with a corresponding
type I receptor kinase and activates it by phosphorylation.
The activated type I receptor kinase then transmits the TGF-
h signal by phosphorylating receptor-regulated Smads (R-
Smads), which are integral signal transducing elements in a
variety of TGF-h pathways. Subsequently, the phosphory-
lated R-Smads complex with a common Smad (Co-Smad)
and translocate into the nucleus. The R-Smad/Co-Smad
complex then interacts with transcription factors, thereby
regulating the expression of their target genes (Hanai et al.,
1999; Liu et al., 1995; Miyazono et al., 1994; Ventura et al.,
1994; Miyazawa et al., 2002; Weis-Garcia and Massague,
1996; Wrana et al., 1994).
In C. elegans, there are at least two well-characterized
TGFh-like signaling pathways. They are the Sma/Mab
(small and male abnormal) and the Daf (dauer formation)
pathways (Patterson and Padgett, 2000). The Sma/Mab
pathway regulates body size and male tail development
(Morita et al., 1999; Savage et al., 1996; Suzuki et al.,
1999), while the Daf pathway regulates the formation of the
dauer (alternative larval stage) when the worm population is
excessive and/or food is scarce (Riddle and Albert, 1997).
Interestingly, both pathways utilize the same type II
receptor, DAF-4 (Krishna et al., 1999). As a result, the
daf-4 mutants have a small body size and a defective male
tail, which are the typical consequences of mutations in
Sma/Mab pathway components, as well as the constitutive
dauer formation defects that result from mutations in Daf
pathway elements.
The type I receptor (SMA-6, Krishna et al., 1999) and
three Smad proteins (SMA-2, SMA-3, and SMA-4, Savage
et al., 1996) that participate in C. elegans Sma/Mab
pathway have also been identified. Mutations in these genes
result in a smaller body size, fusion between rays 4 and 5, 6
and 7, and 8 and 9, and crumpled copulatory spicules in
male tails (Krishna et al., 1999; Savage et al., 1996; Savage-
Dunn et al., 2000). The downstream target genes, lon-1 and
lon-3, whose mutations result in a longer body than the wild
type, were also identified in the Sma/Mab TGF-h signaling
pathway (Maduzia et al., 2002; Suzuki et al., 2002).
Recently, SMA-9 was reported as a transcriptional cofactor
that confers specificity to Sma/Mab pathway (Liang et al.,
2003). SMA-9 regulates the body size during early larval
stages and formation of ray 9 in male tail, suggesting that
other transcriptional factors need to regulate the body size at
late postembryonic stage and other dopaminergic rays of
male tail (Liang et al., 2003).
Polyomavirus enhancer-binding protein 2/core-binding
factor (PEBP2/CBF) is a heterodimeric transcription factor
that is composed of a and h subunits (Bae and Ito, 1999;
Bae et al., 1994; Ogawa et al., 1993a,b; Wang et al.,
1993). The a subunit contains a highly conserved 128-
amino acid region that is termed the Runt domain
(Kagoshima et al., 1993) after the Drosophila runt gene
(Kania et al., 1990), and it binds directly to DNA. Incontrast, the h subunit interacts with Runt domain and
enhances the DNA binding of a subunit. There are three
genes in mammals that encode the a subunits, namely,
RUNX1/AML1/PEBP2aB (Bae et al., 1993; Miyoshi et al.,
1991), RUNX2/CBFA1/PEBP2aA (Ogawa et al., 1993b),
and RUNX3/AML2/PEBP2aC (Bae et al., 1995; Levanon
et al., 1994). These RUNX proteins play important roles in
both normal developmental processes and carcinogenesis.
RUNX1 is essential for definitive hematopoiesis (Okuda et
al., 1996). This gene is located at the breakpoint of the
chromosome translocations that are associated with human
leukemia (Golub et al., 1995; Miyoshi et al., 1993;
Romana et al., 1995) and is responsible for about 30%
of human acute leukemia cases. (Look, 1997). RUNX2 is
required for osteoblast maturation and osteogenesis. Mice
bearing a homozygous mutation in RUNX2 died just after
birth due to an inability to breathe that was caused by
complete lack of ossification (Komori et al., 1997; Otto et
al., 1997). RUNX2 haploinsufficiency also causes the
human bone disease cleidocranial dysplasia (Lee et al.,
1997; Mundlos et al., 1997). RUNX3 has been shown to be
involved in neurogenesis of the dorsal root ganglia, T-cell
differentiation (Levanon et al., 2002; Woolf et al., 2003),
and tumorigenesis of gastric epithelium (Li et al., 2002;
Guo et al., 2002). These RUNX transcription factors are
also integral components of the signaling cascades that are
mediated by both TGF-h and BMPs in several important
biological systems. RUNXs bind to R-Smad and Co-Smad
(Alliston et al., 2001; Hanai et al., 1999), and RUNX2
interacts with BMP-specific Smads and cooperates in
inducing osteoblast differentiation (Zhang et al., 2000).
C. elegans has only one homologue of the mamma-
lian RUNX genes, namely, rnt-1 which has a very
conserved Runt domain (Bae and Lee, 2000). This rnt-
1 gene has been reported to be expressed in the nuclei of
hypodermal seam cells and intestinal cells (Nam et al.,
2002). Interestingly, the RNA interference targeted to rnt-
1 gene shows the malfunction of the hypodermis and
intestine, suggesting that rnt-1 may be involved in the
development of the hypodermis and intestine in C.
elegans. Here, we reported another function of the rnt-
1 which is involved in regulation of body size and male
tail development.Materials and methods
C. elegans strains
The nematode C. elegans Bristol type (N2), CB1482
sma-6(e1482)II , LT186 sma-6 (wk7)II , CB502 sma-
2(e502)III, CB491 sma-3(e491)III, PR675 tax-6(p675)IV,
DR1369 sma-4(e729)III, CB185 lon-1(e185)III, PY1479
kin-29(oy38)X, and DR466 him-5(e1490)V were obtained
from the Caenorhabditis Genetics Center at the University
of Minnesota (St. Paul, MN). The KJ300 cnb-1(jh103)V
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(Park et al., 2001), has been reported previously by
Bandyopadhyay et al. (2002). The VC200 rnt-1(ok351)I
strain was isolated by the C. elegans Knockout Consortium.
Worm breeding and handling were conducted as described
(Brenner, 1974).
Body length measurement of adult worms
The rnt-1(ok351) mutant was outcrossed more than six
times before any characterization was performed. Wild-type
and mutant worms (20 each) were fed for 3–5 h at 208C to
induce the laying of embryos. When these F1 embryos
became young adults after 90 h (72 h for the rnt-
1(ok351);lon-1(e185) and lon-1(e185) mutants), animals
were transferred to a 2% agarose pad and anesthetized with
NaN3 at a concentration of 50 mM for few minutes. Their
body lengths were measured under a Nomarski microscope
(Olympus BX50; Olympus, Tokyo, Japan).
The rnt-1(ok351);lon-1(e185) double mutants were
easily ruptured when they became adult. It was difficult to
measure the body length of adult rnt-1(ok351);lon-1(e185)
mutants, because fully grown worms are more easily
ruptured. To avoid this problem, we measured the body
length of lon-1(e185) and rnt-1(ok351);lon-1(e185) at 72 h
after being laid which was 18 h earlier than other double
mutants to avoid the problem.
Characterization of male tail defects
To facilitate male tail analysis, each strain, including the
rnt-1(ok351) mutant, was crossed with him-5(e1490)V to
generate a double mutant (see below). The animals were
propagated on NGM plates and harvested with M9 buffer,
followed by three washes. The animals were then anes-
thetized with NaN3 on 2% agarose pads and observed under
a Nomarski microscope to score the defects in the spicules
or rays.
Generation of double mutants bearing the rnt-1(ok351)
mutation and a mutation in the Sma/Mab pathway gene
Double mutants containing mutations in the sma-6, sma-
2, sma-3, sma-4, tax-6, kin-29, cnb-1, and rnt-1 genes were
constructed by crossing rnt-1(ok351) heterozygote males
with the homozygous hermaphrodites of each mutant. The
resulting F1 trans-heterozygous hermaphrodites were
cloned, and heterozygosity for the rnt-1 mutation was
confirmed by PCR using primer sets described in Fig. 1. In
the F2 generation, small mutants were carefully counted,
and the phenotypic homozygotes were placed onto separate
plates. Their rnt-1 genotypes were confirmed by PCR. The
Sma hermaphrodites that bore a rnt-1(ok351) homozygous
gene were selected as double mutants.
Double mutants containing mutations in the rnt-1, sma-
6, sma-2, sma-3, sma-4, and him-5(e1490) genes wereconstructed by crossing him-5(e1490) males with the
hermaphrodites of each mutant. Non-Sma hermaphroditic
progenies that resulted from these crosses were placed onto
separate plates. The Sma hermaphrodites in the F2
generation were cloned on separate plates, and the plates
bearing high frequencies of males were selected as double
mutants.
Triple mutants bearing the rnt-1(ok351), sma-[2, 3, 4,
or 6], and him-5(e1490) mutations were constructed by
crossing him-5(e1490) males with the hermaphrodites of
each double mutant [rnt-1;sma-2, rnt-1;sma-3, rnt-1;sma-
4, or rnt-1;sma-6]. The non-Sma hermaphroditic proge-
nies that resulted from the crosses were cloned onto
separate plates. The Sma hermaphrodites that have a high
frequency of males were selected as the sma-[2, 3, 4,
6];him-5 double homozygous animals. The rnt-1 geno-
type of these animals was assessed by using specific
primer sets, which allowed the triple mutant animals to be
selected.
RT–PCR and sequencing
Total RNA was prepared from wild-type animals of
mixed stages as described Sambrook and Russell (2001).
The first strand of cDNA was synthesized by using 5 Ag of
total RNA and Sensiscript (Qiagene Cat. No. 205211) with
the specific primer 5V-TAGTCGGAGAAGAACTATTC-
GATGA-3V according to the manufacturer’s instructions.
The single cDNA strand was amplified by PCR by using 5V-
CTATCAATTTGGGCTGGAAATGACG-3Vas the upstream
primer and 5V-AAAGTGCAGCTGAGATAGAAGG-3V as
the downstream primer. The amplified DNA fragment was
subcloned into the pGEM-T easy vector (Promega, Madi-
son, WI) and sequenced using the T7 and SP6 primers.
Transformation rescue and expression studies
To rescue the rnt-1(ok351) mutant phenotype, rnt-
1(ok351) and rnt-1(ok351);him-5(e1490) mutant animals
were coinjected with the run-FLDgfp fusion construct (Nam
et al., 2002) along with the rol-6 transformation marker at
final concentrations of 50 and 100 Ag/ml, respectively, as
previously described (Mello and Fire, 1995). Individual
Rol-6 and green fluorescent protein (GFP)-expressing
progenies were then picked, and their phenotypes were
examined.
Immunoprecipitation and immunoblot analysis
Two hundred ninety-three cells were transfected with
sma-4 tagged with the Myc epitope and rnt-1 tagged with
HA or Flag epitope, and lysed in ice-cold lysis buffer (25
mM HEPES [pH 7.5], 150 mM NaCl, 1% NP-40, 0.25% Na
deoxycholate, 10% glycerol, 25 mM NaF, 1 mM EDTA, 1
mM Na3VO4, 250 M phenylmethylsulfonyl fluoride, 10 g/
ml leupeptin, 10 g/ml aprotinin) and cleared by centrifuga-
Fig. 1. Schematic representation of the rnt-1 gene and the region that was deleted in the rnt-(ok351) mutant. (A) Genetic and physical maps of rnt-1 in C.
elegans. The rnt-1 gene is located on chromosome I between the dyp-5 and the unc-13 loci of the genetic map and physically maps to the Cosmid B0414
(GeneBank accession number AF003145). (B) Gene structure of rnt-1 and the region that was deleted in the rnt-1(ok351) mutant. The rnt-1 gene is composed
of 11 exons (indicated by boxes). The coding regions are represented by shadowed boxes. The upper line indicates the Runt domain, which is highly conserved
among humans, mice, chicks, Drosophila melanogaster, and C. elegans. The lower lines indicate the region of the rnt-1 genomic DNA that is deleted in rnt-
1(ok351) mutant and the predicted lengths of the PCR products generated by each set of primers as indicated by the arrowheads. (C) The RNA transcripts of the
rnt-1(ok351) mutant. The RT–PCR and sequencing experiment detected rnt-1(ok351) mRNA, which lacks the eighth exon of wild-type mRNA. (D) Amino
acid sequence of RNT-1. The Runt domain is underlined, and the black box indicates the region of the protein that is deleted in the rnt-1(ok351) mutant. (E)
Single worm PCR results. PCR bands obtained from single worms using the primer sets described in B were used to determine whether the animals were
homozygotes (/), heterozygotes (+/), or wild type (+/+). The absence of a 1.7-kb band in the lower panel (/) confirms that the animal is a homozygote.
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appropriate antibodies plus protein G-sepharose beads,
followed by incubation at 48C. The immunoprecipitates
were washed extensively, resolved by SDS–PAGE, and
analyzed by Western blotting using the appropriated anti-
bodies. Antibodies used for immunoprecipitation were anti-
Myc (9E10, Santa Cruz) and anti-Flag (M2, Sigma).
Glutathione S-transferase (GST) pull-down assay
GST pull-down experiments were performed to test
physical interaction between RNT-1 and SMA-4. A GST-
fusion protein containing the full-length RNT-1 protein was
expressed in bacteria and purified. Two hundred ninety-
three cells were transfected with full-length sma-4 tagged
with the Myc epitope, and the cells were lysed in ice cold
lysis buffer (25 mM HEPES [pH 7.5], 150 mM NaCl, 1%
NP-40, 0.25% Na deoxycholate, 10% glycerol, 25 mM NaF,
1 mM EDTA, 1 mM Na3VO4, 250 M phenylmethylsulfonyl
fluoride, 10 g/ml leupeptin, 10 g/ml aprotinin). One milli-
gram of the lysate was incubated with the glutathione–
sepharose beads-bound GST–RNT-1 in 1 ml of ice cold
lysis buffer containing 0.5% of the NP-40. The mixture was
then washed vigorously five times with 1 ml of the samebuffer. After boiling in the SDS sample buffer, the mixtures
were analyzed by SDS–polyacrylamide gel electrophoresis
(SDS–PAGE) followed by Western blotting using an anti-
Myc antibody (9E10, Santa Cruz).Results
The rnt-1(ok351) mutation bears a deletion
The rnt-1 gene was previously found to encode the only
C. elegans homolog of the mammalian RUNX proteins,
which are the a subunits of the CBF/PEBP2 transcription
factor (Bae and Lee, 2000). The rnt-1 gene physically maps
to Cosmid B0414 between the dpy-5 and the unc-13 loci on
the cluster region of linkage group I (Fig. 1A). This gene
was previously characterized and was found to contain 11
exons and to encode a 301-amino acid predicted protein
(Figs. 1B, D) that contains the conserved Runt domain (Bae
and Lee, 2000).
A rnt-1 deletion mutant, rnt-1(ok351), was isolated by
the C. elegans Knockout Consortium (kindly provided by
R. Barstead, Oklahoma), and this led us to further
investigate the function of rnt-1 in C. elegans. First, we
Table 1
The rnt-1(ok351) mutant and Sma/Mab mutants show synergistic effect for
body length
Genotype Body length % n P valuea
N2 1.46 F 0.07 100 17
rnt-1(ok351) 1.16 F 0.10 79.4 48 b0.001
rnt-1(ok351);Ex[pPD-run-FL] 1.34 F 0.08 92.1 46 b0.001
sma-6(e1482) 0.99 F 0.11 66.1 48
rnt-1(ok351);sma-6(e1482) 0.75 F 0.11 50.2 22 b0.001
sma-6(wk7) 1.01 F 0.08 68.0 44
rnt-1(ok351);sma-6(wk7) 0.86 F 0.08 57.9 45 b0.001
sma-2(e502) 0.84 F 0.08 56.1 45
rnt-1(ok351);sma-2(e502) 0.74 F 0.09 49.9 13 b0.05
sma-3(e491) 0.90 F 0.07 62.0 49
rnt-1(ok351); sma-3(e491) 0.84 F 0.12 56.6 45 b0.05
sma-4(e729) 1.01 F 0.09 67.5 46
rnt-1(ok351); sma-4(e729) 0.91 F 0.06 61.0 49 b0.001
lon-1(e185)b 1.52 F 0.15 124.6 32
rnt-1(ok351);lon-1(e185)b 1.51 F 0.25 122.8 18 N0.05
tax-6(p675) 0.96 F 0.11 64.4 87
rnt-1(ok351); tax-6(p675) 0.97 F 0.08 66.6 48 N0.05
kin-29(oy38) 0.96 F 0.08 64.4 44
rnt-1(ok351); kin-29(oy38) 0.98 F 0.07 67.3 47 N0.05
cnb-1(jh103) 0.94 F 0.06 64.6 47
rnt-1(ok351);cnb-1(jh103) 0.95 F 0.06 65.2 50 N0.05
a The P values were calculated using Microsoft office Excel to show the
statistical probability when compared to the numbers in the upper row.
b The body lengths were measured at 72 h after being laid, and the
percentages of body length were calculated relative to wild-type body
length at the same time.
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1(ok351) mutant. The deletion removed approximately 1.5
kb of the rnt-1 gene that spanned the eighth intron to the
ninth intron (Figs. 1B, E). RT–PCR and DNA sequencing
revealed that transcription generated rnt-1 mRNA which
was spliced exactly from the seventh exon to the ninth exon
(Fig. 1C), which would result in the deletion of 38 amino
acids, including 9 amino acids of the Runt domain (Fig.
1D). According to the recently solved X-ray crystal
structure of the Runt domain, this deleted region of Runt
domain corresponds to the C-terminal DNA-binding loop
(Tahirov et al., 2001; Zhang et al., 2003). Therefore, this
deletion mutation may affect the DNA-binding activity of
RNT-1. However, given that the rnt-1(ok351) mutant still
produces rnt-1 mRNA, albeit in a spliced form, it is possible
that the mutated RNT-1 protein may still retain functions
that are independent of its DNA-binding activity (see
Discussion).
For the further analysis of rnt-1(ok351) mutant as
described below, homozygote animals were first identified
by nested PCR. Homozygosity was indicated by a 0.9-kb
DNA fragment produced by the primers located outside of
the deletion region and the absence of a 1.7-kb band when
the inner primers were used (Fig. 1E). The homozygous
animals were then outcrossed more than six times to
eliminate any other possible mutations.
The rnt-1(ok351) mutant has a small body size and male tail
defects
Interestingly, the rnt-1(ok351) mutant did not show gross
defects as adults or any developmental defects. However,
when we observed the mutant more closely, we found that
its brood size was slightly decreased compared to the wild-
type animal, as the number of progeny per single worm was
274 F 50 for the wild-type and 215 F 63 for rnt-1(ok351).
We then measured the body length and found that the
average body length of rnt-1(ok351) is 1.16 F 0.10 mm,
whereas that of the wild-type animal (N2) is 1.46 F 0.07
mm (Table 1). This indicates that the body length of the rnt-
1(ok351) mutant is approximately 20% smaller than that of
the wild-type animal (Table 1 and Fig. 2).
To characterize the rnt-1(ok351) male in more detail,
we generated a male population by using the him-
5(e1490)V background (see Materials and methods). The
male tail of wild-type worm has nine pairs of rays, which are
chemosensory organs, and a pair of spicules, which is a
bilaterally symmetric copulatory structure. Each of the nine
pairs of rays, which are surrounded by round fan, is unique
with respect to its morphology, position, and chemo-
sensitivity. Interestingly, the tail of the rnt-1(ok351) male
is severely deformed (Fig. 3), as the rays were frequently
absent, fused, misaligned, or shortened compared to those of
the control him-5(e1490) males. Furthermore, the shape of
the fan surrounding the nine pairs of rays was quite
irregular.To confirm that the small body size and the defective
male tail are caused by the mutation in the rnt-1 gene, rnt-
1(ok351) mutant animals were injected with the pPD-run-
FL construct, which contains the full-length genomic rnt-1
DNA fused to the gfp (green fluorescent protein) reporter
gene (Nam et al., 2002). Both the small body size and
defective male tail phenotypes of the rnt-1(ok351) mutant
animal were rescued by the pPD-run-FL transformation
(Tables 1 and 2, and Figs. 2C and 3F). This indicates that
these defects are specifically caused by the rnt-1(ok351)
mutation.
The small body size and male tail defects of the rnt-
1(ok351) mutant are very similar to the phenotypes of
animals that bear a mutation in a Sma/Mab TGF-h signaling
pathway component. An example of such mutants is the
sma-6(wk7) mutant, which bears a mutation in the sma-6
gene, the receptor kinase type I of the Sma/Mab pathway in
C. elegans (Tables 1 and 2 and Figs. 2D and 3E). This
resemblance encouraged us to investigate the relationship
between RNT-1 and the Sma/Mab pathway.
rnt-1 is expressed in the male tail
rnt-1 was previously reported to be expressed in the
nuclei of hypodermal seam cells and intestinal cells
(Nam et al., 2002). However, the defects in the male tail
of rnt-1(ok351) led us to monitor the spatial rnt-1
expression pattern in the male tail by injecting the pPD-
run-FL construct into him-5(e1490) animals. The GFP
Fig. 2. Body size of the rnt-1(ok351) single and double mutants. (A)
Nomarski image of wild type (100%), (B) rnt-1(ok351) (79.4% of the
length of wild type), (C) rnt-1(ok351)[pPD-run-FL] (92.1%), (D) sma-
6(wk7) (68%), and (E) rnt-1(ok351);sma-6(wk7) (57.9%) animals. The
animals are all shown at the same magnitude. Bar indicates 20 Am.
Y.-J. Ji et al. / Developmental Biology 274 (2004) 402–412 407reporter protein was indeed detected in the descendant
cells of the V5, V6, and T lineages, which include all
the A-type neuron, the B-type neuron, and the structuralFig. 3. Male tail defects of rnt-1(ok351) animals. (A) Nomarski image of him-5
1(ok351) male tails show a shortened ray (indicated by arrowhead in B), fused
(indicated by an arrowhead in D). (E) The sma-6(wk7) male tail shows fusion of ra
has been rescued by transformation with the pPD-run-FL construct shows nine
reporter gene expression pattern of rnt-1. G shows the Nomarski image of H. GFP
the intestinal and hypodermal seam cells.cells of the rays from the mid-L3 stage to L4 stage
(Figs. 3G and H).
The Sma/Mab TGF-h signaling pathway genes in C.
elegans have been reported to be expressed in the
hypodermis, intestine, pharynx, and male tail. This has
been observed, for example, for the sma-6 gene that
encodes the type I receptor specific for the Sma/Mab
pathway (Krishna et al., 1999) and for the sma-3 gene
that encodes the cytosolic Smad signal transducer (Wang
et al., 2002). These expression patterns overlap well with
the rnt-1 expression pattern apart from the pharyngeal
expression. Taken together, our observation suggests that
rnt-1 may participate in the Sma/Mab pathway, which
regulates body length and male tail development (Krishna
et al., 1999; Savage et al., 1996; Savage-Dunn et al.,
2000).
The rnt-1(ok351) mutant shows synergistic effects with
known mutants of Sma/Mab pathway genes
To investigate the relationship between rnt-1 and the
genes that are known to be involved in the Sma/Mab
pathway, genetic analyses were performed using several
double mutants. Mutations in these known Sma/Mab
pathway genes all result in small body size (Table 1 and
Fig. 2D). Two mutant sma-6 alleles have been identified,
e1482 and wk7, and these appear to be a loss-of-function
mutant and a null mutant, respectively. Both alleles result in
small body sizes (0.99 F 0.11 mm for e1482 and 1.01 F(e1490) shows nine pairs of normal rays. (B–D) Nomarski images of rnt-
rays, misaligned rays (indicated by an arrowhead in C), and missing rays
ys 6 and 7, as indicated by a black arrow. (F) The rnt-1(ok351) mutant that
normal pairs of rays and a pair of normal elongated spicules. (G–H) GFP
was detected in the male tail (indicated by white arrows in H) in addition to
Table 2
The rnt-1(ok351) mutant and Sma/Mab mutant show the synergistic effect in male tail developments
Genotype Frequency of ray fusion or ray missing (%) % Abnormal
spicule
n (Half sides)
1 2 3 4 5 6 7 8 9
him-5(e1490) 0 0 0 0 0 0 0 0 0 1 73
rnt-1(ok351);him-5(e1490) 2 2 15 70 70 47 8 0 0 25 53
rnt-1(ok351);him-5(e1490), Ex[pPD-run-FL:] 9 12 12 11 6 8 11 5 5 8 66
sma-6(wk7);him-5(e1490) 0 8 11 25 37 63 52 8 1 92 73
rnt-1(ok351);sma-6(wk7);him-5(e1490) 69 77 63 62 71 58 44 49 53 81 78
sma-6(e1482);him-5(e1490) 0 0 0 0 0 4 4 0 0 0 50
rnt-1(ok351);sma-6(e1482);him-5(e1490) 12 22 15 68 73 61 22 10 7 26 74
sma-2(e502);him-5(e1490) 0 0 1 14 16 85 85 14 11 91 74
rnt-1(ok351);sma-2(e502);him-5(e1490) 60 71 56 78 78 55 53 47 30 89 73
sma-3(e491);him-5(e1490) 2 2 2 12 32 74 60 11 4 95 54
rnt-1(ok351);sma-3(e491);him-5(e1490) 57 76 55 76 81 59 60 45 38 79 58
sma-4(e729);him-5(e1490) 1 1 0 10 18 83 81 13 5 91 77
rnt-1(ok351);sma-4(e729);him-5(e1490) 58 73 50 59 70 66 44 40 36 97 64
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Surprisingly, the rnt-1(ok351)I;sma-6(e1482)II and rnt-
1(ok351)I;sma-6(wk7)II double mutants have much smaller
body sizes than either of the rnt-1(ok351), sma-6(e1482), or
sma-6(wk7) single mutants (Table 1). The double mutants
containing the rnt-1(ok351) mutation plus a mutation in the
sma-2, sma-3, or sma-4 gene also have much smaller body
size than either the rnt-1(ok351) or sma-2, sma-3, or sma-4
single mutants (Table 1). In contrast, double mutants
containing the rnt-1(ok351) mutation plus a mutation in
one of three genes known to be not involved in TGF-h
signaling, namely, tax-6(p675)IV, cnb-1(jh103)V, and kin-
29(oy38)X, do not have an enhanced decrease in body
length (Table 1). The tax-6 and cnb-1 genes encode
calcineurin A and B and are involved in G-protein-coupled
signaling pathways (Bandyopadhyay et al., 2002). The kin-
29 gene encodes a serine/threonine kinase and is known to
regulate chemoreceptor expression, body size, and dauer
formation (Lanjuin and Sengupta, 2002). Mutations in these
genes all cause a small body phenotype without male tail
defects.
To confirm the effects of RNT-1 in the Sma/Mab TGF-h
signaling pathway, we also observed the male tails of the
double mutants bearing the rnt-1(ok351) mutation together
with a mutation in sma-2, -3, -4, or -6. The sma-6(wk7),
sma-2(e502), sma-3(e491), and sma-4(e729) single mutants
frequently show fusion between rays 4 and 5, 6 and 7, and 8
and 9, and crumpled copulatory spicules. The exception to
this is the loss-of-function allele sma-6(e1482), which does
not show these male tail defects. As described above and
shown in Figs. 3B–D, the rnt-1(ok351) mutant animals
exhibit various male tail abnormalities, including the
frequent absence of several rays, fused rays, and shortened
rays. The shape of fans surrounding the rays is also
irregular. However, the spicules are fully elongated and
appear to be normal. When the rnt-1(ok351) mutation
occurs together with a mutation in sma-2, -3, -4, or -6, the
male tail defects are enhanced since more rays were
deformed in the double mutants than in the single mutants,and the spicules were crumpled much more frequently
(Table 2).
The phenotype of lon-1(e185), which is the downstream target
mutant of Sma/Mab pathway, is epistatic to the rnt-1(ok351)
mutant phenotype
The lon-1 gene, which encodes a PR-related protein,
has been previously identified as one of the downstream
genes that regulate body length (Morita et al., 2002).
Intriguingly, the expression of lon-1 has been shown to be
suppressed by the Sma/Mab TGF-h signaling pathway
(Maduzia et al., 2002). LON-1 appears to be a negative
regulator of body-length in C. elegans since a loss-of-
function mutant, lon-1(e185), has a much longer body
length (Table 1), while overexpression of lon-1 has been
shown to cause a small body size (Morita et al., 2002). To
examine whether there is a genetic interaction between rnt-
1(ok351) and lon-1(e185), the rnt-1(ok351);lon-1(e185)
double mutants were generated. At first, this rnt-
1(ok351);lon-1 double mutants appeared thin and long
like bsmall snake,Q which looked very similar to lon-
1(e185). However, the body length of rnt-1(ok351);lon-
1(e185) double mutants were little shorter than lon-
1(e185) mutants when we measured body length at 90 h
after being laid [1.61F 0.11 mm for lon-1(e185) and 1.47F
0.17 mm for rnt-1(ok351);lon-1(e185)]. Upon more careful
examination, they had an additional phenotype. The rnt-
1(ok351);lon-1(e185) double mutants were easily ruptured
even in the NGM when they reached adulthood. This
might have biased to measure somewhat smaller worms at
90 h after being laid, since many fully grown double
mutants were ruptured dead. Thus, we remeasured the
body length as they grow during developmental stages
(Fig. 4). Interestingly, the rnt-1(ok351);lon-1(e185) double
mutants showed the long phenotype which was identical to
the phenotype of lon-1(e185) during development until 72
h after being laid, suggesting lon-1(e185) is epistatic to
rnt-1(ok351).
Fig. 4. Growth curves of N2 wild type, rnt-1(ok351), lon-1(e185), and rnt-
1(ok351);lon-1(e185). The body lengths of mutants were measured at
various time points after being laid. The measurement of the rnt-
1(ok351);lon-1(e185) double mutants at 90 h after being laid was for
nonruptured animals among viable worms.
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To investigate any physical interaction between the Sma/
Mab pathway components and RNT-1, SMA-4 and RNT-1
were transiently transfected into 293 cells and coprecipitated
in two independent reactions (Figs. 5A, B). Changes of
tagging and the antibodies for immunoprecipitation and
Western blotting showed essentially the same result (Fig.
5B) which indicate that the RNT-1 physically interacts with
SMA-4.
A GST pull-down assay was also performed. SMA-4
was expressed in a mammalian cell line, and the cell lysate
was added to glutathione–sepharose-bound GST–RNT-1.
An association between SMA-4 and GST–RNT was
detected, while this association was undetectable whenFig. 5. Physical interaction of RNT-1 with SMA-4. (A–B) sma-4 Tagged with th
transfected into 293 cells, and protein extracts obtained from the cells were an
antibodies. (C) GST–RNT or GST alone were incubated with a protein extract of
plasmid. Ten percent of the protein extract used for the assay was applied as cont
anti-Myc antibody.GST was used (Fig. 5C). Thus, RNT-1 can physically
interact with SMA-4 in vitro.Discussion
rnt-1(ok351) might be a reduction-of-function mutant
All three mammalian rnt-1 homologues, the RUNX
genes, are essential for survival and play important roles in
hematopoiesis, osteogenesis, and suppression of gastric
cancer. For instance, runx1(/) mice die around E12.5
due to the absence of the myeloid and erythroid
progenitors of definitive hematopoietic origin in either
the yolk sac or fetal livers (Okuda et al., 1996). This
suggests that RUNX1 is essential for definitive hematopoi-
esis of all lineages. In addition, runx2(/) mice die just
after birth due to an inability to breathe because of a
complete lack of ossification (Komori et al., 1997). This
suggests that RUNX2 plays an essential role in osteo-
genesis. Runx3(/) mice also die soon after birth because
of starvation caused by hyperplasia of gastric epithelial
cells, which indicates that RUNX3 acts as a suppressor of
gastric cancer (Li et al., 2002). Since rnt-1 is the only
homologue found in C. elegans, it is likely to be essential
for C. elegans development. Supporting this notion, RNA
interference targeted to rnt-1 causes approximately 30%
embryonic lethality and larval lethality (Nam et al., 2002).
However, the rnt-1(ok351) mutant animals did not show
any embryonic or larval lethality. We suggest that the in-
frame deletion of 38 amino acids, including 9 amino acids
of the Runt domain, which results in a mutant protein that
lacks the C-terminal DNA-binding loop, does not com-
pletely knock out the function of RNT-1. It is widely
believed that the sequence-specific DNA binding ofe Myc epitope and rnt-1 tagged with HA or Flag epitope were transiently
alyzed by immunoprecipitation and Western blotting using the indicated
293 cells that had been transfected with a Myc-tagged SMA-4 expression
rol (input). Myc-SMA-4 protein was detected by Western blotting using an
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on their downstream target genes is essential for their
function during development. However, several lines of
evidence from both Drosophila and mouse model systems
suggest that the DNA-binding activity of a transcriptional
factor is not essential for its in vivo function (Wheeler et
al., 2002). An example of a DNA-binding defective mutant
that retains significant in vivo activity is Drosophila Runt,
as this protein represses the engrailed whether its DNA-
binding activity is intact (Wheeler et al., 2002). Similarly,
rnt-1(ok351) may produce an RNT-1 protein that is only
partially inactivated and that retains the DNA binding-
independent activity of the wild-type protein. It is also
supported by the fact that rnt-1(ok351) is a little longer
than the Sma/Mab pathway mutants.
Nevertheless, the mild but characteristic phenotypes of
rnt-1(ok351) have made our study of the genetic interaction
of rnt-1 with other known components of the TGF-h
signaling pathway possible, and we believe that it will be
extremely useful in helping us to identify the other genetic
components for regulating body length or male tail develop-
ment in C. elegans.
Is rnt-1 involved in the Sma/Mab TGF-ß signaling?
The TGF-h signaling pathways appear to be well
conserved throughout evolution, and the genes involved in
the TGF-h signaling pathways of C. elegans have been well
characterized (Patterson and Padgett, 2000). C. elegans
appears to have at least three genetic pathways that have
been proven to deliver the TGF-h signal, namely, the daf-7,
the dbl-1, and the unc-129 pathways. The dbl-1 pathway
regulates body length and male tail development, and hence
this pathway is also called the Sma/Mab pathway (Sma for
the phenotype of small body size and Mab for the phenotype
of male abnormal phenotype). Many components of this
pathway have been identified, and these include the type I
receptor SMA-6 (Krishna et al., 1999), the type II receptor
DAF-4 (Estevez et al., 1993), the TGFh-like ligand DBL-1
(Morita et al., 1999), and the cytosolic Smads SMA-2, -3,
and -4 (Savage et al., 1996). These mutants have identical
phenotypes which all show small body size and male tail
defects.
The rnt-1(ok351) mutants show small body size and
male tail defects, which are similar phenotypes of the Sma/
Mab pathway mutants, and the spatial expression pattern of
rnt-1 gene also overlaps with that of the genes in the Sma/
Mab pathway. Moreover, numerous reports indicate that
mammalian homologues, RUNXs, interact with Smads in
TGF-h signaling (Hanai et al., 1999; Alliston et al., 2001;
Zhang et al., 2000). These facts urged us to investigate the
relationship between RNT-1 and the Sma/Mab pathway in
C. elegans. As shown here, double mutants of rnt-1(ok351)
with the Sma/Mab pathway mutants show synergistic
effects to regulate the body length and male tail develop-
ment. In addition, we have shown that RNT-1 physicallyinteracts with SMA-4, which is one of the Sma/Mab
pathway regulators. Our data suggest two possibilities. One
possible interpretation is that RNT-1 is involved in
regulation of body length and male tail development which
is new and parallel with the Sma/Mab pathway. Genetic
synergism, rather than epistasis, and slight differences of
male tail defects between rnt-1(ok351) and the Sma/Mab
pathway mutants support this idea. However, many lines of
evidence from mammalian studies, which suggest that
RUNX is the transcription factor in TGF-h signaling,
weaken this possibility. The other possibility is that rnt-1 is
a transcription factor in the Sma/Mab TGF-h signaling
pathway. First, the physical interaction between RNT-1 and
SMA-4, which is the first biochemical evidence shown in
the Sma/Mab pathway, supports this possibility. Second,
when we carefully reexamined the rnt-1(ok351);lon-
1(e185) double mutants, it appeared that lon-1(e185) is
epistatic to rnt-1(ok351), suggesting that lon-1 could be a
downstream target of rnt-1. Indeed, we have identified
possible RNT-1-binding sequences at the 5V- upstream of
the lon-1 gene. However, in contrast to the previous
mutants of the Sma/Mab pathway which have shown
classic genetic epistasis, rnt-1 mutants show synergistic
effects with these mutants in the pathway. Therefore, it is
quite possible that RNT-1 has nonoverlapping function in
addition to its role in TGF-h signaling, and we cannot rule
out the possibility that rnt-1 and the Sma/Mab pathway act
parallel to regulate the body size and male tail develop-
ment. We hope that further characterization of the rnt-
1(ok351) or other alleles of rnt-1 mutants will resolve this
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